We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience. You can read our Cookie Policy here.

Advertisement
ALS study reveals role of RNA-binding proteins
News

ALS study reveals role of RNA-binding proteins

ALS study reveals role of RNA-binding proteins
News

ALS study reveals role of RNA-binding proteins

Read time:
 

Want a FREE PDF version of This News Story?

Complete the form below and we will email you a PDF version of "ALS study reveals role of RNA-binding proteins"

First Name*
Last Name*
Email Address*
Country*
Company Type*
Job Function*
Would you like to receive further email communication from Technology Networks?

Technology Networks Ltd. needs the contact information you provide to us to contact you about our products and services. You may unsubscribe from these communications at any time. For information on how to unsubscribe, as well as our privacy practices and commitment to protecting your privacy, check out our Privacy Policy

Finding provides new therapeutic target -


Although only 10 percent of amyotrophic lateral sclerosis (ALS) cases are hereditary, a significant number of them are caused by mutations that affect proteins that bind RNA. University of California (UC) San Diego School of Medicine researchers studied several ALS cases with a mutation in a RNA-binding protein known as hnRNP A2/B1. In the study, published in Neuron, they describe how damage to this protein contributes to ALS by scrambling crucial cellular messaging systems.


See Also: New approach for treating ALS: Re-evaluating old drugs


"Our findings are a significant step forward in validating RNA-based therapy as a treatment for ALS," said senior author Gene Yeo, PhD, professor of cellular and molecular medicine at UC San Diego School of Medicine.


ALS, also known as Lou Gehrig's disease, is a devastating neurological condition affecting more than 20,000 Americans. The disease greatly diminishes patients' quality of life and is terminal. ALS affects a special kind of nerve cell called a motor neuron. These motor neurons enable us to move our bodies. Currently, there are no effective treatments for ALS, largely due to poor understanding of how the disease initiates and progresses at the molecular level.


Yeo's team studies RNA-binding proteins and their ability to control how, when and if cells make certain proteins. To unravel the role RNA-binding proteins play in ALS, Yeo's team gathered skin cells from four patients with the disease—three with mutations in the hnRNP A2/B1 gene, one with a mutation in a different gene—and two healthy volunteers as controls. The researchers coaxed these skin cells into becoming a special kind of stem cell called induced pluripotent stem cells (iPSCs) and ultimately turned these patient-specific stem cells into motor neurons. This technique provided them with personalized models of each patient's disease, in a laboratory dish, where it's easy to do experiments.


Learn More: New gene variants present in 3 percent of all ALS patients


To determine the effects of the mutant hnRNP A2/B1 proteins in these samples, the researchers then measured the activity of thousands of genes in each of the ALS and healthy motor neuron samples. In the ALS patient samples, Yeo and team found that the hnRNP A2/B1 mutation these patients had didn't merely disable the protein. Instead, the mutation gave the protein new toxic properties that scrambled RNA processing, and ultimately led to the death of motor neurons.


Yeo said these findings may have important implications for their collaborators and others who are developing therapeutics that aim to treat disease by targeting RNA.


"These RNA-targeting therapies can eliminate toxic proteins and treat disease," said first author Fernando Martinez, a graduate student in Yeo's laboratory. "But this strategy is only viable if the proteins have gained new toxic functions through mutation, as we found here for hnRNP A2/B1 in these ALS cases."


Environmental factors are thought to contribute to ALS, increasing the chances a person with a genetic predisposition will get the disease. To mimic this scenario, Martinez compared how motor neurons from ALS patients and healthy individuals respond to stress. In the patient-specific ALS motor neurons under stress, they found more hnRNP A2/B1 proteins clumped in a part of the cells called stress granules, as compared to healthy cells.


Don't Miss: ALS: Renewing brain's aging support cells may help neurons survive


"Drugs that lower the exaggerated reaction to stressors that we saw in motor neurons from ALS patients may also prove a powerful therapeutic strategy," Yeo said. "It is likely that multiple, multi-directional shots at goal will be needed to treat this debilitating disease."


Note: Material may have been edited for length and content. For further information, please contact the cited source.


University of California, San Diego   Original reporting by: Heather Buschman


Publication

Martinez FJ et al. Protein-RNA Networks Regulated by Normal and ALS-Associated Mutant HNRNPA2B1 in the Nervous System.   Neuron, Published Online October 20 2016. doi: 10.1016/j.neuron.2016.09.050


Advertisement